| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/20/2007 | WO2007106469A2 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders |
| 09/20/2007 | WO2007106467A2 Polymorphs of n-(4-chloro-3-methyl-5-isoxazolyl)2-[2-methyl-4,5-(methylenedioxy) phenylacetyl]thiophene-3-sulfonamide, sodium salt |
| 09/20/2007 | WO2007106457A2 Fluidic tissue augmentation compositions and methods |
| 09/20/2007 | WO2007106450A2 Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase in combination therapy |
| 09/20/2007 | WO2007106439A2 Homotropanes with central nervous system activity |
| 09/20/2007 | WO2007106437A2 Quaternary ammonium functionalized glycodendrimers, methods for the production and use thereof |
| 09/20/2007 | WO2007106423A2 Tropane prodrugs with central nervous system activity |
| 09/20/2007 | WO2007106400A2 Pyridine-containing macroheterocylic compounds as kinase inhibitors |
| 09/20/2007 | WO2007106391A1 Compounds for modulating cell proliferation, compositions and methods related thereto |
| 09/20/2007 | WO2007106381A2 Ophthalmic compositions comprising povidone-iodine |
| 09/20/2007 | WO2007106349A2 Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues |
| 09/20/2007 | WO2007106311A2 High-deposition compositions and uses thereof |
| 09/20/2007 | WO2007106264A2 Extended cycle multiphasic oral contraceptive method |
| 09/20/2007 | WO2007106236A2 Pyrrolo-pyridine kinase modulators |
| 09/20/2007 | WO2007106192A2 Inhibitors of iap |
| 09/20/2007 | WO2007106144A1 NOR-SECO-, BIS-NOR-SECO, TRIS-NOR-SECO- AND HIGHER NOR-SECO- CUCURBIT[n]URIL COMPOUNDS |
| 09/20/2007 | WO2007106063A2 Methods for increasing blood flow and/or promoting tissue regeneration |
| 09/20/2007 | WO2007106034A1 New method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewhith, and their use |
| 09/20/2007 | WO2007106022A2 A new crystalline form g of (5s) -5- [4- (5-chloro-pyridin-2- yloxy) -piperidine-1-sulfonylmethyl] - 5 -methyl -imidazolidine - 2,4-dione (i) and intermediates thereof. |
| 09/20/2007 | WO2007106016A1 Bezothiazol derivatives as beta2 adrenoreceptor agonists |
| 09/20/2007 | WO2007105990A1 Inhibitor for differentiation of hematopoietic precursor cells |
| 09/20/2007 | WO2007105984A1 Antimicrobial agent |
| 09/20/2007 | WO2007105978A1 Perfluorocarbon gas transferring emulsion for medico-biological use, the composition and the production method thereof a medicinal agent |
| 09/20/2007 | WO2007105929A1 Synergistic pharmaceutical composition of tramadol and lysine clonixinate |
| 09/20/2007 | WO2007105910A1 A pharmaceutical composition for the treatment of allergic diseases and chronic inflammatory diseases, and a method for treatment of allergic diseases and chronic inflammatory diseases |
| 09/20/2007 | WO2007105864A1 Pharmaceutical composition comprising silymarin for prevention and treatment of irritant contact dermatitis |
| 09/20/2007 | WO2007105854A1 Novel lipoic acid conjugated compounds and skin external applications containing thereof |
| 09/20/2007 | WO2007105823A1 Prophylactic/therapeutic agent for alzheimer's disease |
| 09/20/2007 | WO2007105766A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 09/20/2007 | WO2007105757A1 Composition for foods and drinks having improved hygroscopicity |
| 09/20/2007 | WO2007105753A1 Triazole derivative or salt thereof |
| 09/20/2007 | WO2007105751A1 Quinolone derivative or pharmaceutically acceptable salt thereof |
| 09/20/2007 | WO2007105744A1 Purkinje cell-tropic viral vector |
| 09/20/2007 | WO2007105730A1 Insulin resistance-improving agent |
| 09/20/2007 | WO2007105719A1 Novel substitute material for heparin, and method for production thereof |
| 09/20/2007 | WO2007105706A1 Skin-whitening agent for external application to the skin, and method for whitening the skin |
| 09/20/2007 | WO2007105691A1 Aqueous composition |
| 09/20/2007 | WO2007105637A1 Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient |
| 09/20/2007 | WO2007105621A1 Cardiac dysfunction-ameliorating agent or cardiac function-maintaining agent |
| 09/20/2007 | WO2007105581A1 Antimicrobial agent and antimicrobial composition |
| 09/20/2007 | WO2007105551A1 Novel pyridine derivative having anti-helicobacter pylori activity |
| 09/20/2007 | WO2007105547A1 Method for improving absorbability of myricetin in the body |
| 09/20/2007 | WO2007105353A1 Plant-derived therapeutic agent for malignant tumor |
| 09/20/2007 | WO2007105286A1 Blood lipid level-lowering agent |
| 09/20/2007 | WO2007105210A2 Therapeutic uses of cannabidiol compounds |
| 09/20/2007 | WO2007105203A2 Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels |
| 09/20/2007 | WO2007105190A2 Amyloid and amyloid-like structures |
| 09/20/2007 | WO2007105179A1 Cardioplegic solution |
| 09/20/2007 | WO2007105177A1 Tetrahydroisoquinoline derivatives to enhance memory function |
| 09/20/2007 | WO2007105154A2 Antibiotic compounds |
| 09/20/2007 | WO2007105058A2 Pyrazole compounds |
| 09/20/2007 | WO2007105053A2 Tetralines antagonists of the h-3 receptor |
| 09/20/2007 | WO2007105050A1 Dibenzyl amine compounds and derivatives |
| 09/20/2007 | WO2007105049A1 Dibenzyl amine derivatives as cetp inhibitors |
| 09/20/2007 | WO2007105045A1 Novel bis-2-difluoro-pyrrolo[2,1-c][1,4]benzodiazepine dimmers |
| 09/20/2007 | WO2007105021A2 Duloxetine salts |
| 09/20/2007 | WO2007105016A1 Pharmaceutical spheroids |
| 09/20/2007 | WO2007105015A2 DERIVATIVES OF 18ß-GLYCYRRHETINIC ACID |
| 09/20/2007 | WO2007104985A1 Compositions comprising apocynin , ginkgo and ginger and uses thereo |
| 09/20/2007 | WO2007104981A1 Use of polyamines in the treatment of psoriasis |
| 09/20/2007 | WO2007104959A1 Amino acid derivatives |
| 09/20/2007 | WO2007104944A1 Pyrrolopyrimidine derivatives used as hsp90 inhibitors |
| 09/20/2007 | WO2007104933A1 Chemical compounds |
| 09/20/2007 | WO2007104907A1 Improved formulation of comt inhibitors |
| 09/20/2007 | WO2007104897A1 Topical compositions in the form of an oil-in-water emulsion comprising a pro-penetrating glycol and a steroidal anti-inflammatory drug |
| 09/20/2007 | WO2007104895A1 Topical compositions in the form ofan oil-in-water emulsion comprising a pro-penetrant glycol and a steroidal anti-inflammatory drug |
| 09/20/2007 | WO2007104835A1 Use of a growth-stimulating protein |
| 09/20/2007 | WO2007104790A1 Autoimmune conditions and nadph oxidase defects |
| 09/20/2007 | WO2007104783A2 1,4 -di substituted 3-cyano-pyridone derivatives and their use as positive mglur2-recept0r modulators |
| 09/20/2007 | WO2007104776A1 N-phenyl-2-0x0-1,4-diazaspir0 [4.5] dec-3-en-1-yl acetamide derivatives and their use as glycine transporter inhibitors |
| 09/20/2007 | WO2007104775A1 Compounds which inhibit the glycine transporter and uses thereof |
| 09/20/2007 | WO2007104772A1 Novel enantiomerically pure beta-agonists, method for their production and their use as medicaments |
| 09/20/2007 | WO2007104771A1 Orodispersible domperidone tablets |
| 09/20/2007 | WO2007104723A1 Porphyrin derivates and their use as photosensitizers in photodynamic therapy |
| 09/20/2007 | WO2007104719A1 Diphenylurea derivatives and their use as chloride channel blockers or bkca channel modulators |
| 09/20/2007 | WO2007104717A1 Quinazolinones and their use as potassium channels activators |
| 09/20/2007 | WO2007104696A1 Antimalarial agents having polyaromatic structure |
| 09/20/2007 | WO2007104695A1 Quinolin-4-ylhydrazine derivatives as antimalarial agent |
| 09/20/2007 | WO2007104652A2 Non-peptidic renin inhibitors nitroderivatives |
| 09/20/2007 | WO2007104582A1 Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents |
| 09/20/2007 | WO2007104576A1 Medicament comprising n-acetylmannosamine or derivatives thereof and its use |
| 09/20/2007 | WO2007104575A2 Stable lozenge compositions providing rapid release of nicotine |
| 09/20/2007 | WO2007104574A2 Chewing gum compositions providing rapid release of nicotine |
| 09/20/2007 | WO2007104573A2 Improved snuff composition |
| 09/20/2007 | WO2007104560A1 Substituted 4-amino-quinazoline derivatives as regulators of metabotropic glutamate receptors and their use for producing drugs |
| 09/20/2007 | WO2007104558A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors) |
| 09/20/2007 | WO2007104538A1 Heterobicyclic carboxamides as inhibitors for kinases |
| 09/20/2007 | WO2007104519A1 Use of specific hydrazone compounds for the treatment viral infections |
| 09/20/2007 | WO2007104485A2 Substituted imidazo[2,1-b]thiazole compounds and their use for producing drugs |
| 09/20/2007 | WO2007104474A1 Antifungal compositions comprising (1) a salt of terbinafine with malic acid and (2) malic acid |
| 09/20/2007 | WO2007104254A1 A type of new pyrimidine derivatives having small molecule, preparation methods and uses thereof |
| 09/20/2007 | WO2007104242A1 Compounds capable of inhibiting zinc ion metalloproteinases |
| 09/20/2007 | WO2007104214A1 Camptothecin derivatives and their use |
| 09/20/2007 | WO2007104162A1 Iap bir domain binding compounds |
| 09/20/2007 | WO2007104135A1 Bifunctional polyazamacrocyclic chelating agents |
| 09/20/2007 | WO2007104108A1 Non-codeine opioid analgesic process and formulations |
| 09/20/2007 | WO2007104070A1 Method and composition for treating allergic diseases |
| 09/20/2007 | WO2007090720A3 Use of 2-imidazoles for the treatment of cns disorders |
| 09/20/2007 | WO2007090661A3 Active substance combination comprising azolylcarbinol compounds |
| 09/20/2007 | WO2007088207A3 A process for preparing an organic compound in the solid state and pharmaceutical formulations comprising the said organic compound |